Physician profile
Jonathan Lee Eliason
NPI 1831177161
$5,596.87
in general payments reported to CMS, 2019-2025
7 companies · $1,788 in 2025
The $1,788 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,614 · 2022: $180 · 2023: $1,974 · 2024: $41.66 · 2025: $1,788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,386 · Food and Beverage: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,386.12 |
| Food and Beverage | $1,417.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,436.66 | 2019-2025 | Product In Development, Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Silk Road Medical, INC. | $1,060.45 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cook Research Incorporated | $484.80 | 2023 | Zenith Alpha |
| Cook Medical LLC | $285.35 | 2019-2024 | Zenith |
| Penumbra, INC. | $189.90 | 2025 | Ruby Coil |
| Endologix LLC | $139.71 | 2025 | Alto Abdominal Stent Graft System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Eliason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.